재규어 애니멀 헬스(JAGX)는 NASDAQ에 상장된 Healthcare · Biotechnology 기업입니다. 현재가 $0.92 (+16.97%), 시가총액 $0.00B, 52주 범위 $0.23 ~ $6.96.
Jaguar Health, Inc., a commercial-stage pharmaceuticals company, focuses on developing plant-based prescription medicines for people and animals with gastrointestinal distress. It operates through two segments, Animal Health and Human Health. The company focuses on developing and commercializing prescription and non-prescription products for companion and production animals; and human products. Its lead prescription drug is Mytesi, an anti-secretory antidiarrheal drug for the symptomatic relief of non-infectious diarrhea in adults with HIV/AIDS on antiretroviral therapy; and Canalevia-CA1, a prescription drug product for chemotherapy-induced diarrhea in dogs. It is also developing Crofelemer
재규어 애니멀 헬스의 재무제표, 목표주가, 기관투자자(13F) 보유 현황, 관련 뉴스는 BlackQuant에서 실시간으로 확인할 수 있습니다.
재규어 애니멀 헬스의 현재 주가는 $0.92 (+16.97%)입니다. BlackQuant에서 실시간 시세와 차트를 확인할 수 있습니다.
재규어 애니멀 헬스의 시가총액은 약 $0.00B입니다.
Jaguar Health, Inc., a commercial-stage pharmaceuticals company, focuses on developing plant-based prescription medicines for people and animals with gastrointestinal distress. It operates through two